ResMed | RMD - Market Capitalization


ResMed reported $32.82B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 4.84B 1.48B Aug/2026
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 11.01B 2.34B Jun/2026
Cochlear AUD 7.9B 9.15B Aug/2026
Cooper Companies USD 12.27B 3.68B Mar/2026
CSL USD 60.19B 4.3B Aug/2026
Dexcom USD 25.99B 1.82B Jun/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Fisher Paykel Healthcare NZD 21.96B 201.12M Jun/2026
Globus Medical USD 11.69B 2M Mar/2026
Idexx Laboratories USD 48.84B 7.32B Aug/2026
Insulet USD 11.66B 1.12B Aug/2026
Integra LifeSciences USD 1.4B 664M Jun/2026
Intuitive Surgical USD 140.84B 22.89B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Ramsay Health Care AUD 10.02B 2.09B Aug/2026
ResMed USD 32.7B 2.46B Mar/2026
Sigma Healthcare AUD 2.9B 1.78B Jul/2026
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Steris USD 23.01B 1.32B Aug/2026
Teleflex USD 5.3B 99M Mar/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026